BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 24, 2026
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Home
»
Topics
» BioWorld Science, Neurology/psychiatric
BioWorld Science, Neurology/psychiatric
RSS
5-HT1 agonists described by Merck & Co.
Aug. 9, 1996
Actiq to undergo phase III clinical trials
Aug. 9, 1996
Menarini and Lilly sign comarketing agreement
Aug. 9, 1996
Bifemelane claimed for cerebrovascular disorders treatment
July 26, 1996
Research supports role of testosterone in pathogenesis of stroke
July 26, 1996
Immunex issued U.S. patent for Lerk-7
July 26, 1996
ERT therapy enhances clinical response to tacrine in Alzheimer's patients
July 26, 1996
CP-122638: Pfizer's potential treatment for non-migraine emesis
July 26, 1996
5-HT3/NK1 antagonist combination effective in emesis treatment and prevention
July 26, 1996
Vanderbilt University describes ligands for 5-HT3 receptors
July 26, 1996
Previous
1
2
…
2764
2765
2766
2767
2768
2769
2770
2771
2772
…
2796
2797
Next
RSS